Q3 2025 Earnings Call Transcript November 14, 2025 MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Q3 2025 Earnings Call Transcript November 13, 2025 zSpace, Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.2. Operator: Hello, and thank you for participating ...

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...

Revised 2025 Guidance -- Projected cell processing revenue of $93 million to $94 million, representing 26%-28% growth; total ...

Stem beat on revenue but missed on earnings, causing the stock to sell off in after hours. The company’s net loss of $23.8 million was a marked improvement from $148.3 million in the same quarter last ...

Investing.com -- Celldex Therapeutics Inc (NASDAQ:CLDX) reported third-quarter earnings that fell short of analyst expectations on Monday, as the company continues to invest heavily in its pipeline of ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Fate Therapeutics Inc. (FATE) on Thursday reported a loss of $32.3 million in its third quarter. The San Diego-based company said it had a loss of 27 cents per share.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

Enovis’ third quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, but the market reacted ...